Biofrontera Disclosed Failure to Satisfy a Continued Listing Rule or Standard

Résumé détaillé
On November 16, 2026, Biofrontera received notice that its common stock was below Nasdaq's $1.00 minimum bid price for 30 consecutive business days, violating Nasdaq Listing Rule…
On November 16, 2026, Biofrontera received notice that its common stock was below Nasdaq's $1.00 minimum bid price for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on trading, and the company has until May 17, 2027, to regain compliance by meeting the minimum bid price for at least 10 consecutive business days. If it does not, it may qualify for an additional compliance period; delisting is possible if it fails to meet Nasdaq's requirements.
Début de l'article, extrait de TradingView. Pour lire la suite, ouvrez l'article chez le média.
MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.tradingview.com)



